Chang JH - Search Results

1

Clinical features and treatment outcomes of 14 cases of primary ovarian non-Hodgkin's lymphoma: a single-center experience.

Zhao XY, Hong XN, Cao JN, Leaw SJ, Guo Y, Li ZT, Chang JH. Zhao XY, et al. Among authors: chang jh. Med Oncol. 2011 Dec;28(4):1559-64. doi: 10.1007/s12032-010-9578-0. Epub 2010 May 28. Med Oncol. 2011. PMID: 20509008

2

Thalidomide enhanced the efficacy of CHOP chemotherapy in the treatment of diffuse large B cell lymphoma: A phase II study.

Ji D, Li Q, Cao J, Guo Y, Lv F, Liu X, Wang B, Wang L, Luo Z, Chang J, Wu X, Hong X. Ji D, et al. Oncotarget. 2016 May 31;7(22):33331-9. doi: 10.18632/oncotarget.8973. Oncotarget. 2016. PMID: 27129176 Free PMC article. Clinical Trial.

3

The association between XPD Asp312Asn polymorphism and lung cancer risk: a meta-analysis including 16,949 subjects.

Zhang J, Qiu LX, Leaw SJ, Hu XC, Chang JH. Zhang J, et al. Among authors: chang jh. Med Oncol. 2011 Sep;28(3):655-60. doi: 10.1007/s12032-010-9501-8. Epub 2010 Mar 31. Med Oncol. 2011. PMID: 20354818

4

Continuous infusion of 5-FU with split-dose cisplatin: an effective treatment for advanced squamous-cell carcinoma of the head and neck.

Luo Z, Chang J, Guo Y, Yu H, Lu F, Wu X, Li J. Luo Z, et al. Clin Invest Med. 2011 Feb 1;34(1):E8-13. doi: 10.25011/cim.v34i1.14907. Clin Invest Med. 2011. PMID: 21291636 Clinical Trial.

5

A Phase II Study of Gemcitabine, Vincristine, and Cisplatin As Second-Line Treatment for Patients with Advanced Soft Tissue Sarcoma.

Luo Z, Zhang X, Peng W, Wu X, Wang H, Yu H, Wang J, Chang J, Hong X. Luo Z, et al. Medicine (Baltimore). 2015 Oct;94(43):e1777. doi: 10.1097/MD.0000000000001777. Medicine (Baltimore). 2015. PMID: 26512574 Free PMC article. Clinical Trial.

6

A single institution, retrospective study of treatment experience in primary mediastinal germ cell tumors: elucidating the significance of systemic chemotherapy.

Wang JL, Yu H, Guo Y, Hu XC, Pan ZQ, Chang JH, Zhang YW. Wang JL, et al. Among authors: chang jh. Chin Med J (Engl). 2012 Feb;125(4):626-30. Chin Med J (Engl). 2012. PMID: 22490486

7

A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancer.

Liu X, Guo W, Zhang W, Yin J, Zhang J, Zhu X, Liu T, Chen Z, Wang B, Chang J, Lv F, Hong X, Wang H, Wang J, Zhao X, Wu X, Li J. Liu X, et al. BMC Cancer. 2017 Mar 14;17(1):188. doi: 10.1186/s12885-017-3174-z. BMC Cancer. 2017. PMID: 28288572 Free PMC article. Clinical Trial.

8

A Phase I study of KH901, a conditionally replicating granulocyte-macrophage colony-stimulating factor: armed oncolytic adenovirus for the treatment of head and neck cancers.

Chang J, Zhao X, Wu X, Guo Y, Guo H, Cao J, Guo Y, Lou D, Yu D, Li J. Chang J, et al. Cancer Biol Ther. 2009 Apr;8(8):676-82. doi: 10.4161/cbt.8.8.7913. Epub 2009 Apr 22. Cancer Biol Ther. 2009. PMID: 19242097 Free article. Clinical Trial.

9

Pseudomonas aeruginosa preparation plus chemotherapy for advanced non-small-cell lung cancer: a randomized, multicenter, double-blind phase III study.

Chang J, Liu Y, Han B, Zhou C, Bai C, Li J. Chang J, et al. Med Oncol. 2015 May;32(5):139. doi: 10.1007/s12032-015-0583-1. Epub 2015 Mar 24. Med Oncol. 2015. PMID: 25801231 Clinical Trial.

10

Pharmacokinetics of Osimertinib in Chinese Patients With Advanced NSCLC: A Phase 1 Study.

Zhao H, Cao J, Chang J, Zhang Z, Yang L, Wang J, Cantarini M, Zhang L. Zhao H, et al. J Clin Pharmacol. 2018 Apr;58(4):504-513. doi: 10.1002/jcph.1042. Epub 2017 Dec 14. J Clin Pharmacol. 2018. PMID: 29239002 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,251 results

Search Page

Filters